About MobileODT
MobileODT is a company based in Tel Aviv (Israel) founded in 2012 was acquired by Liger Medical in August 2022. MobileODT has raised $10.85 million across 11 funding rounds from investors including HHS, Tristel and Orbimed. MobileODT operates in a competitive market with competitors including Guided Therapeutics, Illumigyn, Mobidiag, Zilico and Biop Medical, among others.
- Headquarter Tel Aviv, Israel
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$10.85 M (USD)
in 11 rounds
-
Latest Funding Round
$2.3 M (USD), Grant
Jan 29, 2021
-
Investors
HHS
& 11 more
-
Employee Count
Not available
-
Acquired by
Liger Medical
(Aug 01, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of MobileODT
Unlock access to complete
Funding Insights of MobileODT
MobileODT has successfully raised a total of $10.85M across 11 strategic funding rounds. The most recent funding activity was a Grant round of $2.3 million completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in MobileODT
MobileODT has secured backing from 12 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Tristel and Orbimed.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made in disruptive health technologies for life-saving impact.
|
Locked | Locked | Locked | |
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Locked | Locked | Locked | |
|
Acceleration of medical device, digital health, and diagnostic companies is facilitated worldwide.
|
Locked | Locked | Locked |
Investor details for MobileODT
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MobileODT
Investment portfolio details for MobileODT
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - MobileODT
Detailed financials for MobileODT
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Mobileodt Comparisons
Peer comparison for MobileODT
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of MobileODT
MobileODT operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guided Therapeutics, Illumigyn, Mobidiag, Zilico and Biop Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Light-based devices for cervical cancer diagnostics are developed.
|
|
| Locked | Locked | Locked |
Colonoscope for cervical cancer detection procedures is developed.
|
|
| Locked | Locked | Locked |
In vitro diagnostics for infectious diseases are developed and provided.
|
|
| Locked | Locked | Locked |
Real-time cancer diagnostics via Electrical Impedance Spectroscopy are developed.
|
|
| Locked | Locked | Locked |
Point-of-care diagnostics for cervical cancer are developed.
|
Detailed competitors of MobileODT
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Mobileodt
Complete news archive for MobileODT
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MobileODT
MobileODT was founded in 2012 and raised its 1st funding round 2 years after it was founded.
MobileODT is headquartered in Tel Aviv, Israel.
MobileODT is a funded company, having raised a total of $10.85M across 11 funding rounds to date.
MobileODT is focussed on developing artificially intelligent visual diagnostic tools for cancer screening. It has developed the EVA (Enhanced Visual Assessment) System which is a mobile colposcope equipped with a light source and magnification lens for the enhanced cervical visualization. It also has a secure application for patient image and data capture that enables remote consultation, patient tracking, and referral coordination. It claims that the technology can be extended to any digital camera. It is planning to expand the capabilities to identify skin and oral cancer, among other diseases that can be imaged optically.
MobileODT's top competitors include Periwinkle Technologies, Guided Therapeutics and Mobidiag.
MobileODT has 12 investors. Key investors include HHS, Tristel, Orbimed, National Cancer Institute, and DAI.